Regeneron Pharmaceuticals, Inc.
METHODS FOR PRODUCING AFLIBERCEPT IN CHEMICALLY DEFINED MEDIA HAVING REDUCED AFLIBERCEPT VARIANTS
Last updated:
Abstract:
The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions.
Status:
Application
Type:
Utility
Filling date:
21 Dec 2021
Issue date:
28 Apr 2022